DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "IMS Pharmaceutical Pricing & Reimbursement Concise Guide: USA" report to their offering.
The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets.
This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.
Key Topics Covered:
1. HEALTHCARE SYSTEM
- Provision & Funding
- Patient Protection and Affordable Care Act
- Medicare
- Medicaid
- Uninsured
2. PRICING
- Prescription Drugs
- Price Controversies
- Pricing Benchmarks
- Private Payers
- Medicare
- Medicaid
- Generic Drugs
- Private Payers
- Medicare
- Medicaid
- Hospital Drugs
- Procurement
- 340B Drug Programme
- OTC Drugs
3. REIMBURSEMENT
- Admission to Reimbursement
- Private Payers
- Medicare
- Medicaid
- Other Federal Programmes
- Reimbursement Categories
- Private Payers
- Reimbursement Prices
- Hospital Reimbursement
- 340B Programme
- Changes in Reimbursement Status
- Changes in Reimbursement Prices
4. PHARMACOECONOMICS
- Pharmacoeconomic Requirements
- Private Payers
- Medicare
- Medicaid
- Patient-Centered Outcomes Research Institute
5. PRICE BUILD UP
- Wholesalers
- Margins
- Background
- Retail Pharmacies
- Margins
- Dispensing Fees
- Background
- Dispensing Doctors
- Sales Tax
- Prescription Drugs
- OTC Drugs
6. COST CONTAINMENT
- Industry Paybacks
- Annual Fees
- User Fees
- Promotional Costs
- Advertising
- Payments to Physicians
- Patient Co-payments
- Private Payers
- Medicare
- Medicaid
- Pharmaceutical Assistance Programmes
- Uninsured
- Prescribing Controls
- Formularies
- Utilisation Controls
- Off-label Prescribing
- Monitoring
- Other Initiatives
- Generics
7. FUTURE DEVELOPMENTS
- Healthcare Reform
- Drug Pricing Proposals
- Medicare Part D Price Negotiations
- Medicare Part B Reimbursement Reform
- Medicaid Rebate
- State-level Action on Drug Pricing
- MAC Transparency
8. NAMES & ADDRESSES
For more information about this report visit http://www.researchandmarkets.com/research/kf5qvr/ims
